Evaluation of anti-VEGFR-3 specific scFv antibodies as potential therapeutic and diagnostic tools for tumor lymph-angiogenesis

Oncology Reports

Volumn 18, Issue 4, 2007, Pages 933-941

  Zehnder Fjällman, Ann H M ^a   Marty, Cornelia ^a   Halin, Cornelia ^b   Hohn, Alexander ^a   Schibli, Roger ^a,b   Ballmer Hofer, Kurt ^a   Schwendener, Reto A ^a  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

Lymph angiogenesis; Therapeutic and diagnostic single chain fragment antibodies; Tumor targeting; Vascular endothelial growth factor receptor 3

Indexed keywords

IMMUNOGLOBULIN FRAGMENT; PEPTIDE LIBRARY; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MODEL; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; METABOLISM; MOUSE; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TERATOCARCINOMA; TUMOR CELL LINE; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIBODY SPECIFICITY; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN FRAGMENTS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MICE; PEPTIDE LIBRARY; TERATOCARCINOMA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 38449103874     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.4.933     Document Type: Article

References (21)

1. Tobler NE and Detmar M: Tumor and lymph node lymphangiogenesis - impact on cancer metastasis. J Leukoc Biol 80: 691-696, 2006. (Pubitemid 44835883)
2. Kato S, Shimoda H, Ji RC and Miura M: Lymph-angiogenesis and expression of specific molecules as lymphatic endothelial cell markers. Anat Sci Int 81: 71-83, 2006. (Pubitemid 43805637)
3. Saharinen P, Tammela T, Karkkainen MJ and Alitalo K: Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 25: 387-395, 2004. (Pubitemid 38780956)
4. Holash J, Thurston G, Rudge JS, Yancopoulos GD, Adjei AA, Bergers G, Pytowski B, Pegram M and Gordon MS: Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents. Cancer Metastasis Rev 25: 243-252, 2006. (Pubitemid 43886399)
5. Hirakawa S, Kodama S, Kunstfeld RK, Kajiya K, Brown LF and Detmar M: VEGF-A induces tumor and sentinel lymph node lymph-angiogenesis and promotes lymphatic metastasis. J Exp Med 201: 1089-1099, 2005. (Pubitemid 40524677)
6. Bjorndahl MA, Cao R, Burton JB, Brakenhielm E, Religa P, Galter D, Wu L and Cao Y: Vascular endothelial growth factor-A promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res 65: 9261-9268, 2005. (Pubitemid 41507992)
7. Akahane M, Akahane T, Matheny SI, Shah A, Okajima E and Thorgeirsson UP: Vascular endothelial growth factor-D is a survival factor for human breast carcinoma cells. Int J Cancer 118: 841-849, 2006. (Pubitemid 43157659)
8. Yu XM, Lo CY, Chan WF, Lam KY, Leung P and Luk JM: Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases. Clin Cancer Res 11: 8063-8069, 2005. (Pubitemid 41698749)
9. Zeng Y, Opeskin K, Horvath LG, Sutherland RL and Williams ED: Lymphatic vessel density and lymph node metastasis in prostate cancer. Prostate 65: 222-230, 2005. (Pubitemid 41443727)
10. Jussila L, Valtola R, Partanen TA, Salven P, Heikkila P, Matikainen MT, Renkonen R, Kaipainen A, Detmar M, Tschachler E, Alitalo R and Alitalo K: Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 58: 1599-1604, 1998. (Pubitemid 28215077)
11. Shimizu K, Kubo H, Yamaguchi K, Kawashima K, Ueda Y, Matsuo K, Awane M, Shimahara Y, Takabayashi A, Yamaoka Y and Satoh S: Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci 95: 328-333, 2004. (Pubitemid 38519473)
12. Makinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ, Kauppinen R, Jackson DG, Kubo H, Nishikawa S, Yla-Herttuala S and Alitalo K: Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 7: 199-205, 2001. (Pubitemid 32148487)
13. Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Yla-Herttuala S, Jaattela M and Alitalo K: Vascular endothelial growth factor C promotes tumor lymph-angiogenesis and intralymphatic tumor growth. Cancer Res 61: 1786-1790, 2001. (Pubitemid 32691984)
14. Pytowski B, Goldman J, Persaud K, Wu Y, Witte L, Hicklin DJ, Skobe M, Boardman KC and Swartz MA: Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst 97: 14-21, 2005.
15. He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S, Harding T, Jooss K, Takahashi T and Alitalo K: Vascular endothelial cell growth factor receptor-3 mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65: 4739-4746, 2005. (Pubitemid 40740810)
16. Crnic I, Strittmatter K, Cavallaro U, Kopfstein L, Jussila L, Alitalo K and Christofori G: Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis. Cancer Res 64: 8630-8638, 2004. (Pubitemid 39552076)
17. Hoshida T, Isaka N, Hagendoorn J, di Tomaso E, Chen YL, Pytowski B, Fukumura D, Padera TP and Jain RK: Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 66: 8065-8075, 2006. (Pubitemid 44299172)
18. Viti F, Nilsson F, Demartis S, Huber A and Neri D: Design and use of phage display libraries for the selection of antibodies and enzymes. Methods Enzymol 326: 480-505, 2000.
19. Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjallman AH, Ballmer-Hofer K and Schwendener RA: Clodronate-liposome-mediated depletion of tumor-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 95: 272-281, 2006. (Pubitemid 44187587)
20. Rubio Demirovic A, Marty C, Console S, Zeisberger SM, Ruch C, Jaussi R, Schwendener RA and Ballmer-Hofer K: Targeting human cancer cells with VEGF receptor-2-directed liposomes. Oncol Rep 13: 319-324, 2005.
21. Marty C, Langer-Machova Z, Sigrist S, Schott H, Schwendener RA and Ballmer-Hofer K: Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy. Cancer Lett 235: 298-308, 2006.